News

Medical Device Network on MSN10d
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
Edwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients ...
Medical Dialogues5d
FDA Approves Sapien 3 TAVR for Asymptomatic Severe Aortic Stenosis
The US Food and Drugs Administration ( FDA) has approved the Sapien 3 transcatheter aortic valve replacement (TAVR) system ...
MedTech Dive6d
Edwards gains expanded TAVR label for asymptomatic patients
The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement ...
TCTMD10d
FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
Healio10d
FDA approves first TAVR platform to treat severe asymptomatic aortic stenosis
Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...
Treating the Heart Without the Need for Open Heart Surgery
MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery ...
The Bakersfield Californian13d
Transverse Medical Inc. Announces Completion of Series B2 Capital Raise
Transverse Medical Inc., a leading innovator in Cerebral Embolic Protection for stroke prevention during TAVR (Transcatheter Aortic Valve Replacements) and early-stage medical device technology ...
MassDevice10d
Edwards wins FDA nod for TAVR in aortic stenosis without symptoms
Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.
Medscape3d
FDA Approves TAVR in Asymptomatic Severe Stenosis
After a trial shows early intervention prevents hospitalization, the US Food and Drug Administration approves transcatheter ...
Yahoo Finance10d
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
Dr Philippe Genereux, director of the structural heart programme at Gagnon Cardiovascular Institute at Morristown Medical Center, asserted that there is an “urgent need” to change the TAVR ...
Morningstar13d
Transverse Medical Inc. Announces Completion of Series B2 Capital Raise
Point-Guard Protected™ Safeguard the Brain, Treat the Heart. Transverse Medical Inc., a leading innovator in Cerebral Embolic Protection for stroke prevention during TAVR (Transcatheter Aortic ...